Back
ASLAN Pharmaceuticals Vs. CytoMed Therapeutics Industry Stock Comparison
Sell
31
ASLN
ASLAN Pharmaceuticals
Last Price:
0.40
Seasonality Move:
-7.18%
Sell
25
GDTC
CytoMed Therapeutics
Last Price:
2.09
Seasonality Move:
9.26%
Sell
31
ASLAN Pharmaceuticals (ASLN)
is a Sell
Is ASLAN Pharmaceuticals a Buy, Sell or Hold?
- The current ASLAN Pharmaceuticals [ASLN] share price is $0.40. The Score for ASLN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ASLN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
CytoMed Therapeutics (GDTC)
is a Sell
Is CytoMed Therapeutics a Buy, Sell or Hold?
- The current CytoMed Therapeutics [GDTC] share price is $2.07. The Score for GDTC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- GDTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASLN Stock Price Chart
What is ASLAN Pharmaceuticals's stock price today?
-
The ASLAN Pharmaceuticals share price today is $0.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASLN is experiencing slight selling pressure.
GDTC Stock Price Chart
What is CytoMed Therapeutics's stock price today?
-
The CytoMed Therapeutics share price today is $2.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing slight buying pressure.
ASLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 38.49 | Sell |
| Chaikin Money Flow: | -89711 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.42 - 0.5) | Sell |
| Bollinger Bands (100): | (0.42 - 0.72) | Sell |
GDTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 45.97 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.17) | Sell |
| Bollinger Bands (100): | (1.84 - 3.76) | Sell |
ASLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.45 | Sell |
| 50-day SMA: | 0.57 | Sell |
| 200-day SMA: | 1.02 | Sell |
| 8-day EMA: | 0.42 | Sell |
| 20-day EMA: | 0.45 | Sell |
| 50-day EMA: | 0.52 | Sell |
| 200-day EMA: | 1.13 | Sell |
GDTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Sell |
| 20-day SMA: | 2.13 | Sell |
| 50-day SMA: | 2.14 | Sell |
| 200-day SMA: | 3.24 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.12 | Sell |
| 50-day EMA: | 2.25 | Sell |
| 200-day EMA: | 2.9 | Sell |
ASLAN Pharmaceuticals Earnings Growth & ASLN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.73 per share, and an increase next year of $0.99 per share.
CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.00 per share.
ASLAN Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytoMed Therapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||